chrisvoncsefalvay/vaers-outcomes huggingface dataset:
CHILLS; FEVER; FATIGUE; NAUSEA; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced side effects, chills, fever, fatigue, and nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, chills, fatigue, nausea and side effects was not reported. This report was non-serious.20210428439.
T78.40XA ALLERGIC REACTION, INIT 4/24/2023 HX OF AORTIC VALVE REPLACEMENT T78.40XA ALLERGIC REACTION, INIT 4/24/2023 BICUSPID AORTIC VALVE
Swelling of arm; Swelling to upper arm around injection site; Stiffness of joints; Stiffness of joints especially neck; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 02Apr2021 at 20:30 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety and depression. Concomitant medications included sertraline (MANUFACTURER UNKNOWN) for unknown indication and from an unknown date. The patient previously received penicillin (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 03Apr2021 at 17:00, 18 hours after the injection, the patient experienced prolonged, extensive swelling to upper arm around injection site and stiffness of joints, especially neck intensifying with swelling of arm. The adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events was swelling of arm, vaccination site swelling, joint stiffness and neck stiffness and were recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This spontaneous report as received from a Doctor of Osteopathy refers to a 12 year old female patient. The physician reported that the patient received 0.5 ml GARDASIL at month 0 (June 2013), month 2 (August 2013) and month 3 (September 2013) in the vaccination regimen. The physician was asked if the dose was given subcutaneously, and the physician replied "yeah". No adverse effects were reported. It was unspecified if the patient sought medical attention. Additional information has been requested.
Fever for 48 hours.  Spiked at 102.   After 48 hours, congestion in chest.  Wheezing for next 7 days.  Still experiencing coughing/congestion.  Daily headaches, days 6-10
Initial misuse report received from a pharmacist on 07 November 2013.  The 3 female patients had received FLUZONE. It was reported that medical assistant administered expired dose of vaccine to pregnant patients. No adverse event ws reported. List of documents held by sender: none.
Information has been received from a medical office coordinator, concerning a 17 year old female patient who was vaccinated with a dose of PNEUMOVAX vaccine. Concomitant vaccination included Influenza virus vaccine (unspecified). It was reported that the patient experienced cellulitis of the arm after receiving PNEUMOVAX. The medical office coordinator reported that the patient went to the emergency room and was treated with oral antibiotics an other unspecified medication. This is one of two reports from the same source. Additional information has been requested.
Patient is pregnant; This spontaneous pregnancy case was reported by a patient family member or friend and describes the occurrence of MATERNAL EXPOSURE TIMING UNSPECIFIED (Patient is pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.  On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.   Last menstrual period and estimated date of delivery were not provided.   On an unknown date, the patient experienced MATERNAL EXPOSURE TIMING UNSPECIFIED (Patient is pregnant).      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Have been having random low grade fevers (99-100 degrees) my normal temperature is 96.8 and headaches when I wake up in the morning.  After a week the headaches are starting to ease.  The fevers continue.
My formerly healthy 15 yr. old daughter received her one and only dose of the GARDASIL vaccine on July 30, 2009. Since then, she has been plagued with headaches, fatigue, dizziness, numbness and tingling of the legs and feet, non-epileptic seizures, temporary paralysis/blindness, fainting, ovarian cysts, etc. She was hospitalised once and has been to the ER 5 times. She missed nearly the entire school year due to her adverse reaction to the vaccination. She has been evaluation by a psychologist and a psychiatrist both of whom state she is psychologically healthy and well-adjusted. She was recently diagnosed with POTS by a cardiologist. She is on numerous medications and cannot be left alone. I have since learned that there are thousands of other girls experiencing the same thing. If it's not the vaccine, what is it? Please take this vaccine off the market for further study before more innocent lives are compromised.
Employee received her 2nd COVID-19 vaccine on Friday, January 22.  On day 3 of her vaccination she developed neck pain that decreased her ability to turn her head from side to side or look up/down.  She has taken Ibuprofen and one of her husband?s baclofen for relief, and she states that it did not touch the pain, rating it a 5/10.  She has not had any changes in sensation to any of her other extremities, and this pain does not radiate anywhere.  She does state that she does also have a slight headache, but no sensitivity to light.
1st dose given 6/29/21 resulted in headache, swollen glands in neck and extreme muscle aches in neck and shoulder up to top of head. Gave Tylenol for 2 to 3 days.  2nd dose given 1/3/22 resulted in same symptoms as above but also with much worse headache, swollen thyroid and fever for 3 days. Gave Tylenol for 3 days.
PATIENT RECEIVED MODERNA VACCINE IN HER LEFT ARM AROUND 10:25 AM.  WITHIN SECONDS AFTER ADMINISTRATION PATIENT EXPERIENCED VASOVAGAL SYNCOPE.  WOKE UP IN UNDER 10 SECONDS AND FELT LIGHT HEADED AND NAUSEOUS.
heart races a little; feels flushed; checked his pulse and it was a little elevated; eyes are tingly; feeling feverish but no fever; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 51-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, #lot: EL9262) via an unspecified route of administration administered in Arm Right on 25Jan2021 14:00 (at the age of 51-years-old) as single dose for covid-19 immunisation. The patient's medical history included blood pressure. The patient's concomitant medications included hydrochlorothiazide, losartan potassium (LOSARTAN HCTZ) ongoing at 12.5 of unknow units once daily for blood pressure and tamsulosin. The patient underwent lab tests and procedures which included heart rate: little elevated. He checked his pulse and it was a little elevated. It was reported as the patient received the first dose of the pfizer covid 19 vaccine on Monday 25Jan2021 but did not have any symptoms until Thursday 28Jan2021. The patient reported feeling feverish but no fever, heart races a little, eyes are tingly and feels flushed. The patient wants to know if what he is experiencing normal. The patient wanted to know if the rumor is true that the second dose has more side effects. He has had no allergic reactions to medicine. He takes a blood pressure medicine, anti-anxiety medicine, and cholesterol medicine. Starting yesterday he started to feel feverish but had no fever. His eyes started to feel tingly, like a feverish feeling. This started after lunch time. He took a nap for like an hour, slept fine, and then the feeling was gone and he was okay. Today, he woke up this morning around 6:30 AM and was fine. It was not until later this morning around 11 AM when he started to feel the same way again. It was like his heart raced a little. He checked his pulse and it was a little elevated, but nothing crazy. He felt flushed. His eyes were tingly. It is like something does not feel right. He was calling to see if these were side effects. Feeling like his heart was racing has subsided. It was worse earlier. The feeling flushed is minor now. The eyes tingly has almost subsided, but still there. The patient experienced feeling feverish but no fever, eyes are tingly on 28Jan2021, heart races a little, feels flushed and checked his pulse and it was a little elevated on an unspecified date. The outcome of the events heart races a little and eyes are tingly and feels flushed was recovering, while the outcome of remaining events was unknown.  Follow-up attempts are completed. No further information is expected.
02/08/2022 at a dentist visit, they noticed that my blood pressure was high, 175/77 and 60 for heart rate. I then reached out to my primary care in regards to this. They then prescribed me to take 10mg of amlodipine instead of my average 5mg. Symptoms have seemed to be controlled by additional pharmaceuticals but not necessarily cured as of yet. I have also experienced being cold all the time much more easily.
Tongue went numb. Strong taste of metal in my mouth. Lasted two hours then began to subside.  A month later I began having nerve system issues... pain running throughout my joints, moving pain, mostly at night. I went to my doctor who told me to report it and that it could be Guillain Barre Syndrome...
16 yo who received Covid 19 -Pfizer at CVS, on 4/25/21, woke the morning of 4/27/21 with urticaria rash on chest and b/l thighs and presented to pediatrician's office.  Rash cleared with use of Benadryl.  No swelling of lips, or respiratory symptoms.  C/o of local soreness at injection site on 4/26 which was improving on 4/27. No erythema or rash at injection site. No fevers.
My daughter got home and said her arm hurt she started getting fever and she went to sleep right away and she didnt wake up until the next day around 6pm she had high fever 105.4 when she woke up she had a blank stare and was not understanding what I was saying I tried speaking to her and she wasn't aware of her surroundings I gave her a bath and she went back to sleep until the next morning I took her for a walk and she said her joints hurt she couldn't walk more that one block for a few weeks. I wasn't aware my daughter could have died. The doctor never told me anything they had planned to give her 5 vaccines in the one visit. I didn't feel comfortable with that. If I would've know vaccines caused it I would've rushed her to the hospital so they could see what they had done to my daughter.
Subsequent to receiving one dose of varicella virus vaccine live, the pt developed red macules with overlying blisters. Some of the blisters were new and some were large on the arms, thighs, feet, palms and soles. Physician diagnosed probable post Varivax varicella.
Note- This patient did not receive the vaccine at our facility so I do not have further details on the vaccine.   13 y/o female with hx of juvenille arthritis, migraines and anxiety, here for left sided CP, palpitations, fast HR, SOB since 6/8 receiving the 2nd Covid vaccine on 6/6/21. Pt states she is also having some nausea and fatigue. Pt has not taken any medications at home for pain. Pt currently taking methotrexate but no steriods. No family hx of blood clots or blood disorders. Differential Diagnosis: Electrolyte abnormality, dehydration, arrythmia, COVID vaccine reaction, myocarditis r/t COVID vaccine. EKG NSR. negative troponin.
Pt recv vax 08April97 & 16April97 pt devel strep infect of swollen glands,fever & mild sore throat.Pt to see MD. No further info.
Information has been received from a pharmacist concerning her 76 year old husband with a history of thyroid cancer three years ago and had no known drug allergies who on 23-JUN-2010 was vaccinated with a dose of ZOSTAVAX (Merck) (lot number and expiry dates unknown) intramuscularly in his right deltoid. Secondary suspect vaccination administered during the same visit included PNEUMOVAX 23 in his right deltoid. Other concomitant vaccination included tetanus toxoid (manufacturer unknown) in his left deltoid during the same visit. Other concomitant therapy included SYNTHROID, lisinopril-HCTZ and FLOMAX. On 24-JUN-2010, the patient developed a red, warm to touch and painful area of 2 inches in diameter at the site of injection. The patient sought unspecified medical attention. No laboratory tests were performed. the patient was taking naproxen. At the time of the report, the patient had not recovered. No further information is available.
Pt given series of Engerix B vaxs 4Dec89, 2Jan90 &31May90. Serology testing on 29Aug90 showed that pt failed to seroconvert. Pt was 1 of 6 pt who failed to convert out of group of 52. The 52 pts were tested approx 3 mos /p the 3rd dose.
As soon as shot injected, felt a pinched nerve-like pain go down from injection to index finger. Index finger hurt to bend for 5 minutes, and the entire arm was tingly. Felt slight pain and tingles up towards cheek and neck for 1-2 minutes during the time when my finger was hurting. Light headedness started 15 minutes after shot and has continued for 30 minutes.
Breakthrough case admission after 3 vaccines Moderna 2/27/21 Lot# 011A21A;  Moderna 3/27/21 Lot# 018B21A;  Moderna 12/24/21 Lot# 041J21A
This non-serious initial spontaneous case, was received on 27-Sep-2017 from pharmacist, concerning a 48 year-old, adult, female patient. On 25-Sep-2017, the patient was administered with influenza vaccine (dose: 0.5 ml, batch number: (reported as 179604P), expiry date: Apr-2018, route of administration, anatomical location: not reported). On 26-Sep-2017, after vaccination, the subject experienced pain, swelling, redness but it seemed to be getting hotter at injection site. The outcome of the events was not recovered. The reporter assessed the report as non-serious.
gave patient an expired vaccine, Vaccine exp date 06/12/21 given 06/14/21 No adverse reactions Patient is going to get repeat dose when he has his next appointment with our clinic
I noticed Tinitus / Ringing in the ears and it hasn't gone away. Ive only had the first dose so far.
Doses given after temperature excursion; Product storage error; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses given after temperature excursion) and PRODUCT STORAGE ERROR (Product storage error) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039F21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses given after temperature excursion) and PRODUCT STORAGE ERROR (Product storage error). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses given after temperature excursion) and PRODUCT STORAGE ERROR (Product storage error) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Patient received the first half of a Flumist (quadrivalent) and then blew out a lot of snot immediately, she tried biting, kicking, and we were unable to give her the 2nd half of the Flumist.  To make sure she was given a full dose we gave her an influenza; injectable, quadrivalent, preservative free. Patient was fine after receiving the injectable flu vaccine.
exacerbation of underlying autoimmune condition, previously mainly in remission since menopause x 2 years.  Cervicitis, including bloody discharge, ulcers in nose, gums, rash, arthritis.  Started end of January with just minimal symptoms, worsened end of February, peaked 1st week of March.  2nd dose Moderna given 2/11.    Routine adverse events following 1st dose:  1/15 chills, myalgias, rigors, fatigue, anorexia, better by 1/16.  After 2nd dose, mild chills myalgia on 2/12.
Large red circle in the area of the shot, showed up exactly 7 days after the first dose. Very itchy, very hard to the touch and a little painful.
about 30 to 40  minutes after shot on my way home. my lips, tongue, and throat was swelling. Lasted until after 5 pm . the next day through the following day i had burning on my  tongue and mouth. Strange sensation. Slight weakness in my legs through Monday and then i was fine.  On Monday i called my doctor and the doctor suggested that i go for my second shot and let them know of my reaction and let them decide if i should take my second shot.
Pt recvd vax as booster p/gardening injury.P/48 hr pt exp massive edema w/loss of tissue fluid,redness,swelling & fever(101f), enlarged axillary nodes that were tender & palpable. Swelling from shoulder to elbow.
Irregular Periods; High Testosterone Levels; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD TESTOSTERONE INCREASED (High Testosterone Levels) and MENSTRUATION IRREGULAR (Irregular Periods) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for Prophylactic vaccination.     Previously administered products included for Prophylactic vaccination: Janssen COVID 19 vaccine on 11-Apr-2021. Past adverse reactions to the above products included Irregular periods with Janssen COVID 19 vaccine.    In October 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Dec-2021, the patient experienced BLOOD TESTOSTERONE INCREASED (High Testosterone Levels). On an unknown date, the patient experienced MENSTRUATION IRREGULAR (Irregular Periods). At the time of the report, BLOOD TESTOSTERONE INCREASED (High Testosterone Levels) and MENSTRUATION IRREGULAR (Irregular Periods) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Dec-2021, Blood testosterone: high (High) High.         No concomitant medication was provided by the reporter.  No treatment medication was provided by the reporter.
Symptoms onset occurred approx 10 min post administration. Case reports shortness of breath and midsternal chest pain that radiates around her back. She has a history of a cardiac stent one year ago.  BP 110/80 HR 80 SpOx 00% room air LS-CTAB Patient evaluated, she presents anxious and admits to anxiety upon arrival. Highly recommended transfer to a higher level of care. Patient refused EMS transport multiple times, she was accompanied by a passenger in the vehicle. She agreed to stay an additional  30 minutes for continued monitoring and then felt well enough to drive home. She was advised to follow up with her PCP and cardiologist.
Erythema around injection site; Blistering around injection site; This case was reported by a nurse via call center representative and described the occurrence of injection site erythema in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site erythema and injection site blisters. On an unknown date, the outcome of the injection site erythema and injection site blisters were unknown.   It was unknown if the reporter considered the injection site erythema and injection site blisters to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that the patient experienced erythema and blistering around injection site. No demographic details were provided. No lot number or expiration dates were provided. No additional details provided. The healthcare professional did not wish to file adverse event. This case has been linked with cases US2019193803 and US2019AMR196379, reported by the same reporter.
Flu vaccine given in AM around 1000-around 1300 developed S.O.B. legs aching, dizziness SOLUMEDROL, BENADRYL and PREDNISONE in ER
40 doses of Moderna Bivalent vaccine about 10 days beyond use by date to adult patients; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (40 doses of Moderna Bivalent vaccine about 10 days beyond use by date to adult patients) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (40 doses of Moderna Bivalent vaccine about 10 days beyond use by date to adult patients) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (40 doses of Moderna Bivalent vaccine about 10 days beyond use by date to adult patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided      For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.  This is patient number 23th of 40.
Suspected vaccination failure; still got them; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.  On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient still got shingles. The patient stated that, it was not too bad though. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided.
No adverse event. Pt was 17 at time of event, 8 days away from 18th birthday.
Became SOB, gasping respirations, reported feeling like throat was tight when asked. Epi given. Pulse thready. B/P 92/40. Pale, diaphoretic. 911 called. Symptoms improved briefly after first dose of Epi. Then patients respirations became labored and patient began holding neck. Shook head yes when asked if throat was getting tight again. 2nd dose of Epi given. Transported to ED via EMS. Patient observed for over 2 hours. Reported feeling okay. V/s stable. Discharged home.